Trevi Therapeutics Files 8-K Report
Ticker: TRVI · Form: 8-K · Filed: Mar 10, 2025 · CIK: 1563880
Sentiment: neutral
Topics: 8-K, disclosure
TL;DR
Trevi Therapeutics filed an 8-K on 3/10/25 for 'Other Events' - details TBD.
AI Summary
On March 10, 2025, Trevi Therapeutics, Inc. filed an 8-K report. The filing indicates "Other Events" as the primary item of disclosure. No specific financial transactions or material events were detailed in the provided excerpt.
Why It Matters
This filing signals that Trevi Therapeutics has made a disclosure to the SEC, which could pertain to any significant event impacting the company, though specifics are not yet available in this excerpt.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' and does not contain specific negative or positive material information in the provided text.
Key Players & Entities
- Trevi Therapeutics, Inc. (company) — Registrant
- 0000950170-25-036503 (document_id) — Accession Number
- 20250310 (date) — Filing Date
- 195 Church Street, 16th Floor, New Haven, Connecticut 06510 (address) — Principal Executive Offices
- (203) 304-2499 (phone_number) — Registrant's telephone number
FAQ
What is the exact date of the earliest event reported in this 8-K filing?
The earliest event reported is March 10, 2025.
What is the Commission File Number for Trevi Therapeutics, Inc.?
The Commission File Number is 001-38886.
What is the IRS Employer Identification Number for Trevi Therapeutics, Inc.?
The IRS Employer Identification Number is 45-0834299.
What is the primary item of disclosure in this 8-K filing?
The primary item of disclosure is 'Other Events'.
What is the state of incorporation for Trevi Therapeutics, Inc.?
The state of incorporation is Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 10, 2025 regarding Trevi Therapeutics, Inc. (TRVI).